Sales of medical cannabis in Ohio’s tightly restricted market appear to have peaked, as lawmakers continue to stall the launch of the state’s recently legalized adult-use marketplace.
Retail sales of recreational cannabis totaled 412.1 million Canadian dollars ($305.8 million) in November, a decline of 6.2% from October.
Colorado cannabis sales continued to slide in November as recreational and medical marijuana retailers generated $110.5 million in revenue, the lowest monthly total since February 2017.
Consumers in Illinois spent more than $1.6 billion on legal adult-use cannabis in 2023, a market record despite a nearly 15% year-over-year decline in sales to out-of-state shoppers.
A letter from California Attorney General Rob Bonta to state regulators all but ended marijuana industry hopes of interstate cannabis commerce.
Canadian sales of recreational cannabis rose to 448.6 million Canadian dollars in October ($336 million), marking a small increase from the previous month and a 15% increase over the same period last year.
Adult-use cannabis sales in Maryland grew to nearly $56 million in November, a 1.5% increase over October.
Medical cannabis dispensaries in Arkansas have sold more than $1 billion in MMJ products since the program launched in 2019.
Adult-use cannabis sales in Rhode Island have increased steadily each month since the state launched its recreational program one year ago, but medical marijuana sales declined.
Colorado’s cannabis sales continue to slump in 2023, with transactions in every month bringing in less than the same month last year.
Connecticut regulators are increasing the limit on how much adult-use cannabis that retailers can legally sell per transaction.
Medical cannabis patients in Arkansas spent $211.3 million on MMJ between Jan. 1 and the end of September as the state’s legal marijuana market approaches new heights.
